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Abstract 
Current proposed mechanisms implicate both early and latent Epstein–Barr virus (EBV) infection in the carcinogenic 
cascade, whereas epidemiological studies have always associated nasopharyngeal carcinoma (NPC) with early child-
hood EBV infection and with chronic ear, nose, and sinus conditions. Moreover, most patients with NPC present with 
IgA antibody titers to EBV capsid antigen (VCA-IgA), which can precede actual tumor presentation by several years. 
If early childhood EBV infection indeed constitutes a key event in NPC carcinogenesis, one would have to explain 
the inability to detect the virus in normal nasopharyngeal epithelium of patients at a high risk for EBV infection. It is 
perhaps possible that EBV resides within the salivary glands, instead of the epithelium, during latency. This claim is 
indirectly supported by observations that the East Asian phenotype shares the characteristics of an increased sus-
ceptibility to NPC and immature salivary gland morphogenesis, the latter of which is influenced by the association 
of salivary gland morphogenesis with an evolutionary variant of the human ectodysplasin receptor gene (EDAR), 
EDARV370A. Whether the immature salivary gland represents a more favorable nidus for EBV is uncertain, but in 
patients with infectious mononucleosis, EBV has been isolated in this anatomical organ. The presence of EBV-induced 
lymphoepitheliomas in the salivary glands and lungs further addresses the possibility of submucosal spread of the 
virus. Adding to the fact that the fossa of Rosen Müller contains a transformative zone active only in the first decade of 
life, one might be tempted to speculate the possibility of an alternative carcinogenic cascade for NPC that is perhaps 
not dissimilar to the model of human papillomavirus and cervical cancer.
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Introduction
Nasopharyngeal carcinoma (NPC) is the most common 
cancer originating in the nasopharynx, arising from the 
squamous mucosal epithelium of the nasopharynx, most 
often within the fossa of Rosen Müller. Interestingly, NPC 
is a prevalent cancer in a few specific populations, includ-
ing natives of South China, Southeast Asia, the Arctic, 
and the Middle East/North Africa, where the age-stand-
ardized rate of NPC incidences can be as high as 21 per 
100,000 person-years, compared with the incidence in 
the rest of the world, which is generally less than 1 per 
100,000 person-years [1].
The Epstein–Barr virus (EBV) has been definitively 
implicated in the pathogenesis of NPC [2]. Other better 
known factors that contribute to the variation in epide-
miological distribution have been dietary preferences 
rich in nitrosamines, such as preserved foods and salted 
fish [3, 4], and the inheritance of the human leukocyte 
antigen (HLA)- and the non-HLA-related genetic sus-
ceptibility loci [1, 5, 6].
Wee et al. [7] postulated previously that genetic poly-
morphisms on Toll-like receptor 8 (TLR-8) and HLA 
haplotypes in Southeast/East Asians, as a result of 
ancient human migration patterns, may have rendered 
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these ethnic groups more susceptible to infection-associ-
ated cancers, including NPC. In this paper, we postulate a 
mechanism for the genetic transmission and subsequent 
pathogenesis of NPC, building on the ideas of the prior 
paper, as well as in-depth studies on the epidemiological, 
genetic, and immunological characteristics of this sus-
ceptible patient group.
Background
Common genetic susceptibility of Southeast/East Asians 
to chronic infections
Wee et al. [8] first postulated that all populations at risk 
of NPC within Asia were traceable by blood linkage to 
the Bai-Yue ancestral population as a result of the migra-
tion histories of the peoples of Southeast Asia.
Furthermore, based on genetic and anthropological 
evidence, this group might have inherited unique genetic 
polymorphisms as a result of a genetic bottleneck occur-
ring at the Last Glacial Maximum more than 30,000 years 
ago, which may explain their susceptibility to chronic 
infections and, thus, infection-associated cancers such as 
NPC [8].
EBV‑associated disease patterns
EBV has been implicated in carcinogenesis since the 
discovery of its implication in Burkitt’s lymphoma in 
sub-Saharan Africa in the 1960s [9]. The virus has been 
found to be a potent lymphotropic agent that is capable 
of transforming B cells in vitro into a state of continuous 
proliferation called “immortalization.” In recent years, 
both serological detection of elevated virus titers and 
molecular techniques permitting detection of latent EBV 
within tumor cells have reinforced the role of EBV in 
the pathogenesis of several malignancies [10]. However, 
EBV-associated conditions have unique patterns of epi-
demiological predilection.
EBV-associated diseases that are common among East 
Asians but rare in non-East Asian populations include 
natural killer (NK)/T cell lymphomas and NPC; in con-
trast, conditions that are more rarely found in East 
Asians but are common in the western world include 
infectious mononucleosis (IM) and its associated condi-
tions—multiple sclerosis (MS) and EBV-related Hodg-
kin’s lymphoma (HL). It would thus appear that the East 
Asian phenotype may be vulnerable to some EBV-related 
conditions but is equally protective against other condi-
tions associated with the same virus.
It has been postulated that early exposure to EBV could 
contribute to protecting East Asians from IM and MS, 
which are much more common in western countries [11]. 
Personal hygiene and genetic transmission have been 
proposed to result in EBV infection in the early years 
of life. In any case, it may be logical to infer that early 
infection predisposes one to NK/T-cell lymphomas and 
NPC, whereas those who are not exposed to early infec-
tion with EBV are more likely to develop IM and MS later 
in life.
Genetic susceptibility and chronic EBV infection
Considering the genetic factors and EBV-associated dis-
ease patterns, our proposed theory of the mechanism 
aims to unify these observations and explain the carcino-
genic cascade of NPC. We propose that there is a com-
mon genetic susceptibility in populations that are prone 
to NPC as a result of common ancestral origins, which in 
turn results in a tendency towards EBV chronic infection 
at an early age. Thereafter, the addition of some environ-
mental insult (such as nitrosamines as previously pro-
posed [4, 5]) results in the malignant transformation of 
the nasopharyngeal epithelium to NPC.
Early EBV infection and chronic sino‑nasal 
conditions
Early EBV infection
Epidemiological studies have always associated NPC 
with EBV infection in early life [12]. When EBV infection 
occurs later, perhaps in the teens, it is more likely to be 
associated with IM and HL.
Considering HL, the incidence pattern of this malig-
nancy follows a conspicuous bimodal age distribution 
that seemingly varies with the level of socioeconomic 
development and, thus, environmental risk factors. In the 
more affluent western hemisphere populations, HL inci-
dence peaks have been observed in younger adults and 
older adults, but the former is much less apparent in the 
East Asian population, in which reported incidences of 
HL in the first four decades of life are extremely low [13].
However, this has changed in recent decades, as illus-
trated by analyses of data from the population-based 
Singapore Cancer Registry for the period of 1968–2004 
[14], a period during which Singapore had undergone 
marked improvements in socioeconomic and hygiene 
standards towards that of affluent western societies. Over 
time and with the increasing socioeconomic levels, the 
incidence of HL has been increasing in adolescents and 
younger adults, with a distinctive incidence peak emerg-
ing in these age groups. Currently, cities such as Singa-
pore and Hong Kong have a disease pattern of HL almost 
similar to that of a Western society. This could be related 
in part to the possibility that EBV infection is now occur-
ring later in life in these populations. In parallel to this 
phenomenon is the decline in the incidence of NPC in 
both Singapore and Hong Kong but not in certain parts 
of South China, where the socioeconomic status remains 
low. This finding supports the notion that a delay in EBV 
infection changes the pattern of disease from NPC to HL.
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It is also interesting that an apparent latitude effect 
exists for MS (which appears to be related to EBV and 
HL), with this disease affecting mainly those in the tem-
perate countries, except for the Japanese and Greenland 
Eskimos. However, we interpret this to be more related 
to “ethnic” predisposition than latitude, and we argue 
that Japanese and Eskimos, as Mongoloids, are likely 
more susceptible to early EBV infection than Cauca-
sians. Mongoloid is a phenotype that is associated with 
the evolutionary variant of the ectodysplasin A receptor 
(EDAR) gene (EDARV370A) that rise to straight hair and 
increased numbers of sebaceous glands. In the same vein, 
a higher percentage of East Asians (80%) have a unique 
Toll-like receptor 8 (TLR8 gene polymorphism) com-
pared with Caucasians and Africans [15].
Chronic sino‑nasal conditions
Historical epidemiological surveys have consistently 
shown that there appears to be an excess incidence of 
NPC among individuals who have a history of chronic 
ear and nose diseases [15–20]. A study from Chang 
Gung Memorial Hospital, for example, demonstrated 
that NPC patients had a higher incidence of mucosal 
sinus abnormalities especially in the posterior ethmoid 
and sphenoid sinus compared with non-NPC patients, 
and that males had a higher incidence of sinus abnor-
malities compared with females [21]. Additionally, other 
recent papers analysing data from the National Taiwan 
Insurance database demonstrated that the odds ratio 
(OR) of prior chronic rhino-sinusitis (CRS) for subjects 
with NPC is 3.83 [95% confidence interval (CI) 3.23–
4.53] compared with controls after adjusting for income, 
urbanization, geographic location, tobacco use, and 
alcohol abuse/dependence syndrome [22–24]. Individu-
als with ≥4 visits for allergic rhinitis per year were also 
significantly associated with an increased risk of devel-
oping NPC [25].
A previous study from the United States Navy further 
suggested that patients with refractory CRS appeared to 
suffer from a mild to moderate acquired immune defi-
ciency after surgery that was possibly caused by a chronic 
EBV infection [26]. Two papers looking for the presence 
of viruses in specimens obtained from surgery for CRS 
revealed the presence of EBV, suggesting that EBV may 
be a cause for the chronic inflammation [27, 28].
What is also intriguing is that CRS in East Asia appears 
to differ from CRS in the West, with Western CRS hav-
ing a more eosinophilic infiltration (i.e., allergic), whereas 
its Asian counterpart is more neutrophilic (i.e., infec-
tion-related) [29, 30]. In addition to this well-recognized 
difference, a study from Singapore demonstrated that 
a predominant infiltration of lymphocytes, especially 
CD8+ T cells and NK cells, may play a key role in the 
pathogenesis of nasal polyps and chronic sinusitis [31].
Pre‑malignant EBV serological changes
Most NPC patients present with IgA antibodies to EBV 
viral capsid antigen (EBV-VCA) and EBV nuclear antigen 
1 (EBNA1), and previous studies have shown that such 
IgA responses often precede tumor presentation by sev-
eral years [32].
Mechanism for early and chronic EBV infection
“3‑hit” hypothesis for chronic EBV infection
Wee et al. [7] previously proposed that the stark popula-
tion differences in the risks for developing NPC could be 
explained by defects in the subject’s innate immunity and 
cell-mediated immunity, specifically in TLR8 and HLA-
dependent cell-mediated immunity.
Building on the above information, we now propose a 
“3-hit” hypothesis for chronic EBV infection as the ini-
tial process in the NPC carcinogenesis cascade in these 
susceptible population groups. It is characterized by the 
following events in the order indicated: (1) TLR8 poly-
morphism leads to faulty innate immunity; (2) early EBV 
infection occurs during neonatal life; and (3) susceptible 
HLA leads to faulty cell-mediated immunity.
“1st hit”: TLR8 polymorphism
TLRs regulate our innate and adaptive immune response 
to microbial infections and, more recently, have been 
shown to play a role in inflammation and the pathogen-
esis of cancer [33]. Wee et  al. [7] previously proposed 
TLR8 as a likely candidate for susceptibility to NPC 
based on an analysis of past genetic and epidemiological 
research.
First, it has been found that East Asians harbor specific 
polymorphisms in the TLR8 gene that are distinct from 
Caucasians and Africans, which may lead to a functional 
loss/reduction of this immune mechanism [15]. It is fur-
ther suggested that these unique TLR8 polymorphisms 
are a result of evolutionary selection due to human 
migration patterns [7]. It is also interesting to note that 
in the Waldeyer’s ring, TLR8 expression is highly variable 
between patients, indicating a further possible difference 
in susceptibility between patient groups [33].
Another coincidence is the fact that TLR8 is found on 
the X-chromosome (Xp22), which could explain a linkage 
between X-linked recessive polymorphisms in this gene 
and the 3:1 male to female incidence ratio in NPC. This 
would be consistent with the proposal of Hu et  al. [34] 
for a South Chinese-specific, recessive NPC gene that is 
closely linked to the HLA region as a major determinant 
of NPC associated with this population.
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Finally, TLR8 is the only known mature TLR that func-
tions during neonatal life [35]. With increasing age, other 
classes of TLRs are mature and are able to tackle the EBV 
infection, thus compensating for any negative effects due 
to an impaired TLR8 immune response. Collectively, 
these pieces of evidence implicate TLR8 in early EBV 
infection, prior to the progression to a chronic infection.
“2nd hit”: early neonatal infection with EBV
Previous studies have determined that in regions where 
NPC is endemic, primary EBV infections are usually 
acquired at an early age [36]. Serologic surveys have 
shown that primary EBV infections occur generally 
under the age of 5  years and, in most cases, occur dur-
ing infancy in South China, where NPC is most frequent 
[37–39]. This also appears to be the case in Greenland 
Eskimos, another population that is at a high risk for 
NPC and has been postulated to have similar genetic pol-
ymorphisms leading to increased EBV chronic infection 
susceptibility [40].
“3rd hit”: susceptible HLA
The HLA complex is defined by the genes of the major 
histocompatibility complex (MHC) located on the chro-
mosome 6 and they code for cell surface proteins that 
are involved in the antigen presentation for a generation 
of host immune responses. HLA genes possess a large 
number of polymorphisms, with more than 1980 unique 
known alleles and varying allelic frequencies among dif-
ferent racial groups, which result in differences that affect 
either peptide presentation or cellular interactions with 
the T-cell receptor and, consequently, inter-individual 
variation in cell-mediated immunity. With this back-
ground, it is entirely plausible to believe that the genetic 
polymorphisms associated with HLA play a part in 
inducing susceptibility to EBV-related diseases such as 
NPC [10, 41].
On this note, a number of studies have reported asso-
ciations between HLA genes and NPC. A possible asso-
ciation was first identified in Singapore in 1974, when 
examining an association between the HLA-A2 pheno-
type and the risk of NPC among Chinese in Singapore 
[42]. Subsequent studies from high-incidence popula-
tions indicated that individuals with A2 and BW46 or 
with A2–BW46, AW19–B17, and A2–B16 haplotypes are 
at an increased risk of NPC. The individuals with B17*, 
B18*, and B35* alleles from high- and mid-incidence 
populations also have increased frequencies of NPC [43, 
44]. Conversely, A*31, B*13, and the associated haplo-
type A*30–B*13 have been reported to confer protection 
against NPC [44, 45].
Further insights in this regard can be gained by com-
paring the predominant HLA gene haplotypes in 
populations with differing risks of NPC. In the Cha-
oshanese, a population group in the Guangdong Prov-
ince of South China with a high incidence of NPC, the 
HLA alleles B*46, B*38, and B*58 and the related haplo-
types A*02–B*46 and A*33–B*58 have been found to be 
prevalent [45]. These HLA genes have previously been 
positively associated with NPC susceptibility [6, 45]. In 
contrast, A*31 and B*13, two alleles that possess highly 
protective effects on NPC, and the associated haplotype 
A*30–B*13 were predominantly high in northern Chi-
nese, a population with low incidence of NPC [45].
In a study to investigate East Asian genetic diversity, 
Di and Sanchez-Mazas [46] found that some HLA alleles 
observed in southern East Asian populations are virtu-
ally unique in Asia. Thus, HLA A*02-07 and B*46-01, 
which represent the haplotypes with an increased risk 
of NPC are found mainly in southern East Asian popula-
tions and less frequently observed in northern East Asian 
populations.
Recent genome-wide association studies (GWAS) in 
susceptible populations also concluded that NPC is asso-
ciated with HLA genetic variants in the MHC region on 
the chromosome 6.
In addition, we can examine other EBV-associated 
diseases for further evidence of HLA-linked genetic 
susceptibility to EBV chronic infections. Elevated lev-
els of anti-EBV antibodies have been associated with an 
increased risk of HL. It has been shown that HLA class II 
variants influence the anti-EBNA-1 IgG titers in a study 
on a European population, thus reinforcing the role of 
the same variants in the risk of HL [47]. Separately, Hjal-
grim et al. [47] demonstrated that HLA class I-restricted, 
EBV-specific, cytotoxic T-cell responses and events in 
the early immune response to IM play critical roles in the 
pathogenesis of EBV-related HL, whereas Brennan et al. 
[48] demonstrated that inefficient T-cell control over 
the proliferation of EBV-positive B cells and malignant, 
EBV-positive Hodgkin Reed Sternberg cells in individuals 
with the HLA-A*01 allele bears the same effect. Finally, 
in a study of pediatric transplant patients, the HLA-A*02 
allele expression was predominant in patients with a 
chronically high EBV viral load [49].
Taken together, these findings support the notion that 
NPC-prone populations possess variations in HLA gene 
loci that could contribute to a phenotype of impaired 
cell-mediated immunity that is prone to chronic infec-
tions, in this specific instance, EBV infection.
To conclude, we propose the novel, though untested, 
“3-hit” model as the scientific basis for a typical East 
Asian NPC patient to acquire chronic EBV infection:
(a) A germline TLR8 polymorphism (80% allele fre-
quency);
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(b) The inheritance of a susceptible HLA gene locus/
loci (HLA A*0207 and HLA B*4601 have a 13% and 
16% prevalence, respectively, in Hong Kong—the 
total at risk of susceptible HLA gene would then be 
approximately 29%) [50]; and
(c) An infection occurring during neonatal life (assum-
ing a 20% infection rate every 4 months of life [51, 
52], or only 5% per month); with increasing age, 
other TLRs will mature and reduce the likelihood of 
EBV infection.
Extrapolating from these numbers, the crude estimate 
of the “incidence” of individuals fulfilling all three criteria 
would be 1.2% (0.8 × 0.3 × 0.05 = 0.012 or approximately 
1 per 100 persons), which is somewhat in accordance 
with the reported incidences of NPC in Hong Kong [53].
Four studies have examined the presence of EBV in 
“normal” Chinese adults. Chan et al. [54] and Sam et al. 
[55] failed to detect EBV in 23 “normal” nasopharyngeal 
biopsies each. In contrast, Tsai et al. [56] found EBV by 
polymerase chain reaction in 7 of 61 patients without 
neoplasia, and Huang et al. [57] found that only 2 of the 
202 healthy subjects who had elevated antibody levels 
were DNase-positive. Thus, of the 309 total “normal” 
nasopharyngeal biopsies, 9 were found to have EBV, or 
approximately 3 per 100 “normal” subjects, as per our 
estimates.
Salivary gland cell: the epithelial cell harboring 
EBV
Evidence for NPC’s association with salivary gland cells
NPC is widely considered to be squamous in origin, 
although Li et al. [58] proposed that at least one variant 
of NPC might arise from the basal cells of respiratory 
epithelium. That said, an intriguing fact of EBV-asso-
ciated NPC is the inability to detect EBV in the naso-
pharyngeal epithelium of high-risk individuals; however, 
the virus is persistently detected, even in the early stages 
of malignant transformation. One thus wonders whether 
EBV resides in other anatomical sites in the latent stages 
following acute infection. A possible site could be the 
minor salivary glands in the nasopharynx or the adjacent 
oropharynx. The occurrence of “Eskimoma”, a lymphoe-
pithelial carcinoma of the parotid gland that is charac-
terized by raised EBV serology and a similar histology to 
NPC, raises this possibility [59]. Lymphoepithelioma-like 
carcinoma of the lung is another example, and is indistin-
guishable from undifferentiated NPC [60]. In IM, where 
primary transmission is through the saliva, EBV is detect-
able in non-cancer lesions of the salivary glands [61–63], 
again supporting the notion of the salivary gland cell as a 
possible nidus for EBV in the latent phase.
Although NPC is considered histologically to be of 
squamous origin, several pathologists have questioned 
this. Li et al. [58] and Lin et al. [64] proposed that at least 
one variant of NPC might arise from the basal cells of the 
respiratory epithelium.
NPC is also known to spread sub-mucosally. Sham et al. 
[65] demonstrated that approximately 14% of patients 
have the sub-mucosal growth pattern in NPC. Occult 
microscopic extension of a tumor that was not detected 
on endoscopy was found in a further 50% of patients.
Another provocative suggestion in this regard relates 
to the prevalence of EDARV370A among East Asians. 
EDAR is a cell-surface receptor for ectodysplasin A and 
plays a pivotal role in the development of ectodermal tis-
sue. Jaskoll et al. [66] demonstrated that the EDAR gene 
signaling is essential for embryonic submandibular sali-
vary gland development, whereas Kallapravit et  al. [67] 
demonstrated that the histological structures of the seba-
ceous glands in adult Siamese seemed to be more juve-
nile than those of white and black Americans. It is thus 
possible that that the abundance of immaturely formed 
minor salivary glands found in the epithelium of East 
Asians provides a more conducive nidus for EBV.
Mouse model
In a mouse model, Ptaschinski et  al. [68] demonstrated 
that infection of the neonatal mouse with murine gam-
maherpesvirus-68 (γHV-68) results in an enhanced viral 
persistence in the lungs and an absence of IM syndrome. 
They observed that the persistence of the herpes virus 
is age-dependent, as is the development of IM-like syn-
drome. TLR8 is non-functional in mice because it lacks 
five amino acids [69], which may explain why γHV-68 
is found in the lungs of mice when they are infected as 
pups.
Transformation zone in the fossa of Rosen Müller
Histology of the fossa of Rosen Müller
The submucosal glands of the nasopharynx have the his-
tological structure of a salivary gland, being composed 
of mucous and serous acini, as well as mucous acini with 
serous demilunes [70].
It has been demonstrated that in the nasopharynx, 
there is a transitional zone between the ciliated columnar 
respiratory and the stratified squamous epithelium [71]. 
This intermediate epithelium showed gradations ranging 
from stratified low-columnar through stratified cuboi-
dal to stratified squamous type [72]. However, the pres-
ence of this transformational zone is only active during 
the period of fetal development to the first 10 years of life 
[73]; thus, any changes to the epithelium induced by viral 
insults must occur early in life, which would coincide 
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with the period when TLR8 is the only active regulator of 
the host immune response.
The intermediate epithelium appears to be particularly 
susceptible to oncogenic stimuli. It is therefore no coinci-
dence that the areas of the nasopharynx that are the pri-
mary sites of carcinomas are also where the intermediate 
epithelial cells are found in their greatest numbers [74].
Carcinogenic cascade
The subsequent development of NPC within the naso-
pharynx may then follow a “cervical cancer model.” 
Infection with the human papillomavirus (HPV) has 
been established as the primary process for the devel-
opment of cervical cancers. At low passage numbers, 
HPV-immortalized cells are non-tumorigenic. They can 
undergo malignant progression after extended growth 
and exposure to carcinogens or when additional onco-
genes are expressed. Similarly, the progression of high-
risk HPV-positive cervical lesions is a protracted process 
that occurs at a low frequency and requires the acquisi-
tion of host genetic and epigenetic mutations [75]. These 
changes exist primarily at the transformation zone, a 
region where metaplastic squamous cells are detected 
in otherwise columnar epithelial-lined endo-cervical 
glands. Women usually contract HPV between their late 
teenage years and early 30s, when the transformation 
zone is the largest, but there is a long latency to the onset 
of cervical cancer (peak incidence at 45  years of age) 
[76–78].
We postulate that NPC carcinogenesis follows a similar 
model. Neonatal transmission of EBV infects the naso-
pharyngeal epithelium with resultant latency in the basal 
epithelium (salivary gland cells) during the developmen-
tal period of the transformational zone. Entry of the virus 
into the epithelial cells may perhaps be mediated in this 
case by integrin β6 [78]. Exposure to subsequent carcino-
genic insults triggers the carcinogenic cascade that takes 
years for the eventual malignant transformation to NPC.
Testing the hypothesis
Methods that can be used to investigate this hypothesis 
include the following:
1. Histology and pathology of the fossa of Rosen Müller
• Study the temporal changes that occurred in the 
fossa of Rosen Müller (1) from autopsy studies 
of patients in highly endemic regions who died 
of other causes; (2) from biopsies taken during 
surgery for other non-NPC otolaryngological 
conditions in patients in highly endemic NPC 
regions; and (3) from biopsies from subjects in 
NPC screening studies who manifested different 
combinations of EBV serological and EBV DNA 
titers.
2. Mouse models
• Compare the effects of γHV-68 infection in the 
pups of wild type (BALB/c) [68], EDAR370A 
transgenic mice [79], and TLR8 transgenic mice 
[80] (the mouse and human nasopharynx are 
comparatively similar in terms of the epithelium, 
the presence of an intermediate zone, and the 
presence of sero-mucinous glands in the sub-
mucosa [81]. TLR8 is non-functional in mice 
because it lacks five amino acids [71], which 
might explain why γHV-68 is found in the lungs 
of mice when they are infected as pups).
• Expose γHV-68-infected mice (wild-type, 
EDAR370A, and TLR8 transgenic) to chronic 
chemical carcinogens.
• Expose γHV-68-infected rats (infected during 
neonatal period) to chronic chemical carcino-
gens [82, 83].
3. HLA haplotype
• Determine the HLA haplotype of a reasonable 
size cohort of NPC patients.
4. Large animal models
• Use lymphocryptovirus (LCV) and TLR8 antag-
onists to mimic early neonatal EBV infection in 
neonatal rhesus monkeys.
• Test neonatal EBV vaccination strategies.
5. EBV vaccination
• Perform large-scale, population-based, case–
control study of EBV vaccine in neonates, with 
long-term follow-up for NPC patients (currently, 
the only clinically available prophylactic EBV 
vaccine is gp350, which has only demonstrated 
efficacy for the reduction of the rate of IM, but 
not virus infection).
Conclusions
The mechanism and hypothesis set forth in this paper 
offer a convenient explanation for many of the enigmatic 
characteristics of this peculiar cancer, addressing the fol-
lowing points:
1. The predominant Southeast Asian distribution: the 
TLR8 polymorphism is an East Asian signature, and 
the HLA haplotypes associated with it are South Chi-
nese and Southeast Asian haplotypes;
2. The apparent increased susceptibility in certain 
families and the presence of multiple cases of NPC 
in some extended families: families with index cases 
would already have the appropriate TLR8 and HLA 
present and are most likely to be subjected to the 
same practices and environmental insults, which 
Page 7 of 9Poh et al. Chin J Cancer  (2016) 35:9 
would predispose them to “chronic EBV infection” 
and carcinogenesis;
3. The apparent absence of EBV in “normal” naso-
pharyngeal biopsies: our hypothesis proposes that 
the virus will only be found when all three factors in 
our “3-hit” hypothesis are present or, alternatively, 
when other anatomical sites are the potential nidus 
for EBV in the latent phase, thus explaining the lack 
of EBV in the “normal” individuals sampled;
4. Circumstantial evidence for “chronic EBV infection” 
occurring early in life;
5. The unique role of the East Asian phenotype and 
EBV-related conditions; and
6. The decreasing incidence of NPC in HK and Singa-
pore, and the corresponding increase in incidence 
in early HL in the same cities, as explained by the 
acquiring of the chronic EBV infection later in life as 
a result of improved socioeconomic factors.
In addition, the HPV “cervical cancer” model provides 
a mechanism that ties in the factors noted above to the 
proposed carcinogenesis cascade, thus completing the 
picture further.
Some suggested means to test this hypothesis include 
in-depth temporal histological and pathologic studies 
of the fossa of Rosen Müller; the use of mouse (and rat) 
models—exposing them to γHV-68 followed by chemi-
cal carcinogens; the determination of the HLA haplotype 
of NPC patients, and using large animal models to test 
a neonatal EBV vaccination strategy. Vaccination strate-
gies may ultimately reduce the incidence of this cancer in 
endemic areas.
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